Indrayani Biotech Past Earnings Performance
Past criteria checks 2/6
Indrayani Biotech has been growing earnings at an average annual rate of 50.3%, while the Hospitality industry saw earnings growing at 32.9% annually. Revenues have been growing at an average rate of 47% per year. Indrayani Biotech's return on equity is 14.8%, and it has net margins of 2.6%.
Key information
50.3%
Earnings growth rate
40.0%
EPS growth rate
| Hospitality Industry Growth | 30.2% |
| Revenue growth rate | 47.0% |
| Return on equity | 14.8% |
| Net Margin | 2.6% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Indrayani Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,711 | 45 | 245 | 0 |
| 30 Sep 23 | 1,780 | 69 | 263 | 0 |
| 30 Jun 23 | 1,796 | 97 | 245 | 0 |
| 31 Mar 23 | 1,629 | 87 | 253 | 0 |
| 31 Dec 22 | 1,309 | 121 | 186 | 0 |
| 30 Sep 22 | 1,001 | 98 | 145 | 0 |
| 30 Jun 22 | 729 | 56 | 117 | 0 |
| 31 Mar 22 | 616 | 44 | 108 | 0 |
| 31 Dec 21 | 515 | -4 | 101 | 0 |
| 30 Sep 21 | 421 | -33 | 86 | 0 |
| 30 Jun 21 | 320 | -52 | 72 | 0 |
| 31 Mar 21 | 212 | -112 | 67 | 0 |
| 30 Jun 20 | 533 | -45 | 146 | 0 |
| 31 Mar 20 | 499 | 8 | 120 | 0 |
| 30 Jun 19 | 0 | -1 | 2 | 0 |
| 31 Mar 19 | 0 | -1 | 2 | 0 |
Quality Earnings: 526445 has high quality earnings.
Growing Profit Margin: 526445's current net profit margins (2.6%) are lower than last year (9.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 526445 has become profitable over the past 5 years, growing earnings by 50.3% per year.
Accelerating Growth: 526445's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 526445 had negative earnings growth (-62.9%) over the past year, making it difficult to compare to the Hospitality industry average (28.9%).
Return on Equity
High ROE: 526445's Return on Equity (14.8%) is considered low.